What is the current stock price of eFFECTOR Therapeutics, Inc. (EFTR)?

As of the latest market data, eFFECTOR Therapeutics, Inc. (EFTR) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does eFFECTOR Therapeutics, Inc. (EFTR) pay a dividend?

Based on current data, eFFECTOR Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of eFFECTOR Therapeutics, Inc.?

The current market capitalization of eFFECTOR Therapeutics, Inc. (EFTR) is approximately unavailable.

EFTR

eFFECTOR Therapeutics, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.01

Company Profile

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-03-01

Beta

0.89

Websiteeffector.com↗